Nonetheless, a study by the team of Olivares-Urbano et al. [52] on 20 patients under observation before and during radiotherapy treatment showed that MMP-3 reached higher levels in patients with higher grade of BC and among ER/PR-negative BC patients. This evidence concerns the gene ESR1 and breast cancer.